Related Experiment Videos

[Systemic mycotic infections: epidemiology and diagnostic criteria]

J Bille1

  • 1Laboratoire de bactériologie, Centre hospitalier universitaire vaudois, Lausanne.

Schweizerische Medizinische Wochenschrift
|June 10, 1995
PubMed

Insights

Disseminated candidiasis, a growing systemic fungal infection, frequently affects high-risk patients. Early diagnosis and understanding transmission routes are crucial for managing this challenging condition.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Disseminated candidiasis is a frequent and increasing systemic mycosis.
  • High-risk patient groups include neutropenic oncology patients and post-abdominal surgery patients.
  • Predictive factors include prior antibiotics, intravascular devices, prior Candida colonization, and skin barrier disruption.

Purpose of the Study:

  • To review the epidemiology, diagnosis, and transmission of disseminated candidiasis.
  • To highlight diagnostic challenges and emerging molecular methods.
  • To emphasize the role of colonization and transmission in intensive care units.

Main Methods:

  • Review of current literature on disseminated candidiasis.
  • Analysis of diagnostic approaches, including microbiological and anatomopathological methods.
  • Discussion of emerging diagnostic technologies like PCR.

Main Results:

  • Candida albicans remains the predominant species.
  • Diagnosis is often delayed and relies on clinical suspicion and conventional methods.
  • Current antigen/antibody detection methods have suboptimal sensitivity and specificity.
  • Molecular diagnostics (PCR) show promise for improved detection.

Conclusions:

  • Disseminated candidiasis requires a high index of suspicion for timely diagnosis.
  • The human digestive tract is the primary reservoir, with colonization preceding infection.
  • Understanding transmission, especially in ICUs, is vital for infection control.

Related Concept Videos